Catheter ablation is a medical procedure that is used to treat some types of arrhythmia. Heart arrhythmia is group of condition leads to irregular heartbeat. During this procedure a long, thin, flexible tube is placed into blood vessels of neck, arm or groin. This tube is called an ablation catheter which is then guided towards the heart. During the procedure, a system send sends energy through the ablation catheter to the heart. Radiofrequency energy is most commonly used for catheter ablation. The passed energy produces heat that modifies the affected heart tissue (caused of dysrhythmia). Catheter based ablation procedure are totally safe and effective. According to American Heart Association, catheter-based ablation procedure shows 90% success rate and have low risk of complication.
The global radiofrequency ablation catheter market is segmented on the basis of type and geography. On the basis of type the market is further sub segmented into two types irrigated radiofrequency ablation catheter and non-irrigated radiofrequency ablation catheter. Irrigated radiofrequency ablation catheter segment is expected to hold maximum share of the market in forecast period this is because it decreases char and thrombus formation which eventually prevent thromboembolic events (another life-threatening consequence). Increase in incidence and prevalence rate of heart disease, growing ageing population and increased rate of obesity in all age group drives the growth of the global market during forecast period. In addition to it, technological advancement and demographic trend are expected to fuel the growth of the market. However, stringent regulatory environment and entry of other catheter ablation procedure like ‘cryoablation balloon catheters’ may hamper the growth of the global radiofrequency ablation catheter market during forecast period.
On the basis of geography, the global radiofrequency ablation catheter market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In terms of revenue, North America followed by Europe is major contributor for the global radiofrequency ablation catheter market. This is because rise in incidence and prevalence of cardiac and other heart related diseases, presence of developed healthcare infrastructure, increasing research and drug development activities, presence of major players, and large number of product developments (approvals & launch), propels the growth of the market in the region. Asia Pacific is third promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors for this market. Emerging and huge population base countries such as China and India offers tremendous market opportunities for the global radiofrequency ablation catheter market.
Some of the market players leading the global radiofrequency ablation catheter market include Stryker Corporation, Halyard Health, Inc., AtriCure, Inc., Bramsys Medical Systems, Medtronic Plc, St. Jude Medical, Inc., C. R. Bard, Inc., Hologic, Inc., Sutter Medizintechnik GmbH, Epimed International, Boston Scientific Corporation, Arthrex, Inc., AngioDynamics, Inc., Baylis Medical, sfm medical devices GmbH, ENDO-FLEX GmbH, Johnson & Johnson, and inomed Medizintechnik GmbH